Malignant Neoplasm of Stomach Terminated Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02452424A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid TumorsTreatment
NCT02318901Pembrolizumab and Monoclonal Antibody Therapy in Advanced CancerTreatment